These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 8996800)

  • 1. DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
    Chritin M; Blanchard V; Raisman-Vozari R; Feuerstein C; Agid Y; Javoy-Agid F; Savasta M
    Eur J Neurosci; 1996 Dec; 8(12):2511-20. PubMed ID: 8996800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.
    Svenningsson P; Gunne L; Andren PE
    Neuroscience; 2000; 99(3):457-68. PubMed ID: 11029538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-course of changes in striatal levels of DA uptake sites, DA D2 receptor and preproenkephalin mRNAs after nigrostriatal dopaminergic denervation in the rat.
    Chritin M; Feuerstein C; Savasta M
    Brain Res Mol Brain Res; 1993 Sep; 19(4):318-22. PubMed ID: 8231735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE; Wooten GF
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors.
    Jung AB; Bennett JP
    Brain Res Dev Brain Res; 1996 Jul; 94(2):109-20. PubMed ID: 8836569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.
    Gross CE; Ravenscroft P; Dovero S; Jaber M; Bioulac B; Bezard E
    J Neurochem; 2003 Mar; 84(6):1246-55. PubMed ID: 12614325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra.
    Smith JA; Leslie FM; Broide RS; Loughlin SE
    Neuroscience; 1993 Aug; 55(4):935-51. PubMed ID: 8232904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei.
    Meissner W; Dovero S; Bioulac B; Gross CE; Bezard E
    Neurobiol Dis; 2003 Jun; 13(1):46-54. PubMed ID: 12758066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of neonatal 6-hydroxydopamine injections on glutamate decarboxylase, preproenkephalin and dopamine D2 receptor mRNAs in the adult rat striatum.
    Soghomonian JJ
    Brain Res; 1993 Sep; 621(2):249-59. PubMed ID: 7902185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I; Ghorayeb I; Normand E; Bloch B
    J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive gene expression changes on the healthy side of parkinsonian rats.
    Capper-Loup C; Frey CM; Rebell D; Kaelin-Lang A
    Neuroscience; 2013 Mar; 233():157-65. PubMed ID: 23270858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.
    Rots NY; Cools AR; Bérod A; Voorn P; Rostène W; de Kloet ER
    Brain Res; 1996 Feb; 710(1-2):189-96. PubMed ID: 8963658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus.
    Hoover BR; Marshall JF
    Neuroscience; 2002; 111(1):111-25. PubMed ID: 11955716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
    Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
    Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935.
    Mennicken F; Savasta M; Peretti-Renucci R; Feuerstein C
    J Neural Transm Gen Sect; 1992; 87(1):1-14. PubMed ID: 1346964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype of striatal cells expressing c-Fos following amphetamine treatment of rats with intrastriatal dopaminergic grafts.
    Abrous DN; Bernard V; Le Moal M; Bloch B; Herman JP
    Eur J Neurosci; 1996 Dec; 8(12):2521-9. PubMed ID: 8996801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.